CD274 and B-cell non-Hodgkin lymphoma: These results suggest that PD-L1 is affected in a broad spectrum of human malignancies, whereas PD-L2 SVs are largely restricted to B-cell lymphomas, possibly reflecting the expression pattern of PD-1 ligands (Fig. 2b).